Role of nitric oxide in cocaine-induced acute hypertension

American Journal of Hypertension

Volumn 11, Issue 6 I, 1998, Pages 708-714

  Mo, Wa ^a   Singh, Ashok K ^a   Arruda, Jose A L ^c   Dunea, George ^b  

^a Hektoen Institute for Medical Research   (United States)

^b Jr Hospital of Cook County   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cocaine; Endothelium; Hypertension; Nitric oxide; Sympathetic system

Indexed keywords

COCAINE; N(G) METHYLARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CATECHOLAMINE UPTAKE; CONTROLLED STUDY; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; COCAINE; DOPAMINE UPTAKE INHIBITORS; HYPERTENSION; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 0031838964     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00041-7     Document Type: Article

References (25)

1. Ritchie J.M., Green N.M. Local anesthetics. Gilman A.G., Goodman L.S., Rall T.W., Murad F. The Pharmacological Basis of Therapeutics. 1985;309-310 Macmillan, New York.
2. Gillis R.A., Quest J.A., Nilkerson R.D. Mechanisms responsible for cardiovascular disorders associated with cocaine abuse. Lakowski J.M., Galloway M.P., White F.J. Cocaine Pharmacology Physiology and Clinical Strategies. 1992;371-390 CRC Press, Ann Arbor, Michigan.
3. Killam A.L. Cardiovascular and thrombosis pathology associated with cocaine use. Hematol Oncol Clin North Am. 1993;1143-1151.
4. Dunea G., Arruda J.A.L., Bakir A.A., et al. Role of cocaine in end-stage renal disease in some hypertensive African Americans. Am J Nephrol. 15:1995;5-9.
5. Grabowski J: in Cocaine: pharmacology, effects and treatment of abuse, pp 34-53. National Institute on Drug Abuse Research Monograph. No. 50. NIDA, Rockville, Maryland, 1984.
6. Morrison K.J., Vanhoutte P.M. Mechanism of drug action. Singh B.N., Dzau V.J., Vanhoutte P.M., Woosler R.L. The Cardiovascular Pharmacology and Therapeutics. 1994;6-36 Churchill Livingstone, New York.
7. Reese D.D., Palmer R.E., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
8. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide - physiology, pathophysiology and pharmacology. Pharmacol Rev. 43:1991;109-142.
9. Havranek E.P., Koonlawee N., Grayburn P.A., Eichhorn E.J. Endothelium-dependent vasorelaxation is impaired in cocaine arteriopathy. J Am Coll Cardiol. 28:1996;1168-1174.
10. Skrbic R: Prisustvo adrenergickih, serotoninergickih, holinergickih I vip receptora U.lingvalnim arterijiama psa I majmana. (Ph.D Thesis). University of Belgrade Medical School, Belgrade, 1994, pp 38-39.
11. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
12. Furchgott R.F. The requirement for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators. Trends Pharmacol Sci. 2:1981;173-176.
13. Morrissey J.J., Ishidoya S., McCracken R., et al. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol. 7:1996;2202-2212.
14. Pitts D.K., Udom C.E., Mawah J. Cardiovascular effect of cocaine in anesthetized and conscious rats. Life Sciences. 44:1987;1099-1111.
15. Hartman DE: Neuropsychological toxicology of drugs, in Hartman DE (ed): Neuropsychology Toxicology. Identification and Assessment of Human Neurotoxin Syndromes. New York, Pergamon Press, 1988, pp 216-222.
16. Muir J.K., Ellis E.F. Cocaine potentiates the blood pressure and cerebral blood flow response to norepinephrine in rats. Eur J Pharmacol. 249:1993;287-292.
17. Kalsner S. Cocaine sensitization of coronary artery contraction mechanism of drug-induced spasm . J Pharmacol Exp Ther. 264:1993;1132-1140.
18. Vicaut E., Trouve R., Hou X. Microvascular effects of cocaine; interaction with nitredipine and enalarprilat. J Toxicol Clin Toxicol. 29:1991;165-175.
19. Albuquerque M.L.C., Kurth C.D. Cocaine constricts immature cerebral arterioles by local anesthetic mechanism. Eur J Pharmacol. 249:1993;215-220.
20. Shaffer J.E., Han B.J., Chern W.H., Lee F.W. Lack of tolerance to a 24-hour infusion of S-nitroso N-acetylpenicillamine (SNAP) in conscious rabbits. J Pharmacol Exp Ther. 260:1992;286-293.
21. Snyde S.H. Nitric oxide first in a new class of neurotransmitters? Science. 257:1992;494-496.
22. Pudiak C.M., Bozarth M.A. L-NMA and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sciences. 53:1993;1517-1524.
23. Egashira K., Pipers F.S., Morgan J.P. Effects of cocaine on epicardial coronary artery reactivity in miniature swine after endothelial injury and high cholesterol feeding in vitro and in vivo analysis . J Clin Invest. 88:1991;1307-1314.
24. Rand M.J., Li C.G. Nitric oxide as a neurotransmitter in peripheral nerves Nature of transmitter and mechanism of transmission . Ann Rev Physiol. 57:1995;659-687.
25. Yossef I. Nitric oxide (NO) synthase inhibitors abolish cocaine-induced toxicity in mice. Neuropharmacol. 32:1993;1069-1070.